Dramatic response of hepatitis C patients chronically infected with hepatitis C virus genotype 3 to sofosbuvir-based therapies in Punjab, Pakistan: A prospective study

doi:10.3748/wjg.v23.i44.7899

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 44

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6782)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-6) series.

Item

Count

PDF

371

WORD

363

HTML

3181

Tables (1-6)

237

Sum=4152

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1132

Download

1498

Sum=2630

Nov 28, 2017 (publication date) through Nov 21, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Gastroenterol. Nov 28, 2017; 23(44): 7899-7905
Published online Nov 28, 2017. doi: 10.3748/wjg.v23.i44.7899

Table 3 Association of baseline characteristics of the patients with sustained virological response treated with sofosbuvir+ribavirin+peg-interferon alfa-2a (Second group) n (%)

Baseline characteristics (n = 528)	ETR (n = 526), overall ETR 0.9962	SVR (n = 515), overall SVR 0.9791	Relapse (n = 11), overall relapse rate = 2.09%
Age (yr)
≤ 40 (n = 419)	419 (100)	415 (99.05)	4 (0.95)
> 40 (n = 109)	107 (98.17)	100 (93.46)	7 (6.54)
Previous antiviral treatment history
Naïve (n = 399)	399 (100)	396 (99.25)	3 (0.75)
Treated (n = 129)	127 (98.45)	119 (93.70)	8 (6.30)
Gender
Male (n = 386)	386 (100)	382 (98.96)	4 (1.04)
Female (n = 142)	140 (98.59)	133 (95)	7 (5)

ETR: End of therapy response rate; SVR: sustained virological response.

Citation: Iqbal S, Yousuf MH, Yousaf MI. Dramatic response of hepatitis C patients chronically infected with hepatitis C virus genotype 3 to sofosbuvir-based therapies in Punjab, Pakistan: A prospective study. World J Gastroenterol 2017; 23(44): 7899-7905
URL: https://www.wjgnet.com/1007-9327/full/v23/i44/7899.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i44.7899